Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 3/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.37 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16201791 | 1.00 | TRPA1 (0.41) | TRPA1FAAHTRPV1MGLLS1PR2 | |
| SCHEMBL16201793 | 0.95 | TRPA1 (0.41) | TRPA1FAAHTRPV1MGLLS1PR2 | |
| SCHEMBL15004812 | 0.95 | TRPA1 (0.41) | TRPA1FAAHTRPV1MGLLS1PR2 | |
| SCHEMBL16201807 | 0.86 | CASP1 (0.43) | TRPA1FAAHMGLL | |
| SCHEMBL16201794 | 0.84 | FAAH (0.39) | TRPA1FAAHTRPV1MGLLS1PR2 | |
| SCHEMBL15005076 | 0.84 | FAAH (0.39) | TRPA1FAAHTRPV1MGLLS1PR2 | |
| SCHEMBL15012477 | 0.83 | TRPA1 (0.41) | TRPA1FAAHTRPV1MGLLS1PR2 | |
| SCHEMBL15012479 | 0.83 | TRPA1 (0.41) | TRPA1FAAHTRPV1MGLLS1PR2 | |
| SCHEMBL16201780 | 0.83 | CYP2C19 (0.47) | PPARGPPARA | |
| SCHEMBL16201797 | 0.81 | FAAH (0.40) | FAAHMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140323457-A1 | BETA-O/S/N FATTY ACID BASED COMPOUNDS AS ANTIBACTERIAL AND ANTIPROTOZOAL AGENTS | Technische Universität München (DE) | 2014-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140323457-A1 | BETA-O/S/N FATTY ACID BASED COMPOUNDS AS ANTIBACTERIAL AND ANTIPROTOZOAL AGENTS | FASN, DEGS1, EBP | TRPA1 2071/4885FAAH 344/4885TRPV1 1996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.